Skeletal Muscle Mass on Prognosis and Recovery in Clinical Trial
Key facts
- Who runs it
- National Taiwan University Hospital
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 90 people, planned
- Started
- 1 Jun 2025
- Expected to end
- 31 Dec 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Enhanced Rehabilitation Program
- Record updated
- 20 July 2026
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Non-traumatic adult patients who experienced sudden cardiac arrest
- Achieved sustained return of spontaneous circulation (ROSC) for more than five minutes following successful resuscitation
- Admitted to the ICU
- Survived beyond 72 hours without successful weaning from mechanical ventilation
Who cannot take part
- Terminal-stage cancer or unwillingness to receive aggressive treatment
- Open wounds, severe edema, or deep vein thrombosis in the lower limbs
- Age under 18 years
- Pregnancy
- Expected to be weaned from mechanical ventilation within 48 hours
- Unavailability of ICU care due to overcrowding in the emergency intensive care unit
- Refusal to participate in the study by the patient or family members
- Presence of an implanted pacemaker or defibrillator
- Pre-arrest status limited to wheelchair use or bedridden, unable to ambulate
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The objective of this research project is to develop an automated muscle mass measurement system based on computed tomography (CT) images using deep learning and artificial intelligence, and to construct a prognostic prediction model for patients who have experienced cardiac arrest and undergone resuscitation. The model will be validated using multicenter registry data and medical imaging. Furthermore, a clinical trial involving core muscle rehabilitation for post-resuscitation patients will be conducted to evaluate both short-term and long-term outcomes, aiming to comprehensively understand the impact of muscle mass on the prognosis of patients after cardiac arrest.
The 2 groups in the trial
- control groupNo study treatment, for comparison
- Intervention GroupTreatment being tested
Participants in the arm group only performed joint-assisted movement.
Treatment: Enhanced Rehabilitation Program
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comprehensive Interpretation of the Importance of Skeletal Muscle Mass on Prognosis and Recovery in Cardiac Arrest Survivors: From Machine Learning to Clinical Trial
- Criteria questions
- Built from NCT07034170, who can take part
- Record updated
- 20 July 2026